Intended Use

cvi42 Auto is intended to be used for viewing, post-processing, qualitative and quantitative evaluation of cardiovascular magnetic resonance (MR) and computed tomography (CT) images in a Digital Imaging and Communications in Medicine (DICOM) Standard format. It enables a set of tools to assist physicians in qualitative assessment of cardiac images and quantitative measurements of the heart and adjacent vessels; perform calcium scoring; and to confirm the presence or absence of physician-identified lesion in blood vessels. The target population for cvi42 Auto's manual workflows is not restricted; however, cvi42 Auto's semi-automated machine learning algorithms are intended for an adult population. cvi42 Auto shall be used only for cardiac images acquired from an MR or CT scanner. It shall be used by qualified medical professionals, experienced in examining and evaluating cardiovascular MR or CT images, for the purpose of obtaining diagnostic information as part of a comprehensive diagnostic decision-making process.

Technology

cvi42 Auto is a software as a medical device (SaMD) combining digital image processing, visualization, quantification, and reporting tools. It uses machine learning algorithms trained on diverse clinical data for semi-automatic segmentation of the four heart chambers in MR images, calcium scoring using pixel intensity on CT images, and semi-automatic coronary artery centerline placement on CT images. It supports 2D and 3D visualization and operates independently of image acquisition equipment.

Performance

Performance testing included validation of machine learning derived outputs on 235 anonymized patient images from multiple manufacturers and clinical sites. MR function analysis achieved 97%-100% classification accuracy with volume prediction errors between 5%-10%. Calcium scoring classification accuracy ranged from 86%-99%. Coronary artery centerline detection showed 82%-94% performance. All results met pre-defined acceptance criteria.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    12/21/2021

    7 months
  • 2

    FDA Approval

    7/28/2022

Other devices from Circle Cardiovascular Imaging Inc

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.